MGC Pharmaceuticals said this marks the first time an epilepsy treatment containing THC and still undergoing clinical trials was approved by UK authorities for import. The news saw MGC Pharmaceuticals [ASX:MXC] shares jump 10% at the time of writing.
ASX:MXC Chart by TradingView
MGC Pharmaceuticals Ltd (ASX:MXC) Company Information
MGC Pharmaceuticals Ltd (ASX:MXC) Financial Information
ASX:MXC Fundamental Data / Rates by TradingView